Bifogade filer
RaySearch receives additional RayStation order for advanced proton therapy at Stanford Health Care
Kurs
-0,22%
Likviditet
29,1 MSEK
Prenumeration
Kalender
| Est. tid* | ||
| 2026-02-12 | 07:50 | Bokslutskommuniké 2025 |
| 2025-11-07 | 07:50 | Kvartalsrapport 2025-Q3 |
| 2025-08-08 | - | Kvartalsrapport 2025-Q2 |
| 2025-05-23 | - | X-dag ordinarie utdelning RAY B 3.00 SEK |
| 2025-05-22 | - | Årsstämma |
| 2025-05-09 | - | Kvartalsrapport 2025-Q1 |
| 2025-02-21 | - | Bokslutskommuniké 2024 |
| 2024-11-08 | - | Kvartalsrapport 2024-Q3 |
| 2024-08-16 | - | Kvartalsrapport 2024-Q2 |
| 2024-05-23 | - | X-dag bonusutdelning RAY B 1.3 |
| 2024-05-23 | - | X-dag ordinarie utdelning RAY B 0.70 SEK |
| 2024-05-22 | - | Årsstämma |
| 2024-05-17 | - | Kvartalsrapport 2024-Q1 |
| 2024-02-23 | - | Bokslutskommuniké 2023 |
| 2023-11-17 | - | Kvartalsrapport 2023-Q3 |
| 2023-08-25 | - | Kvartalsrapport 2023-Q2 |
| 2023-05-26 | - | X-dag ordinarie utdelning RAY B 0.00 SEK |
| 2023-05-25 | - | Årsstämma |
| 2023-05-17 | - | Kvartalsrapport 2023-Q1 |
| 2023-02-28 | - | Bokslutskommuniké 2022 |
| 2022-11-29 | - | Kvartalsrapport 2022-Q3 |
| 2022-08-29 | - | Kvartalsrapport 2022-Q2 |
| 2022-05-27 | - | X-dag ordinarie utdelning RAY B 0.00 SEK |
| 2022-05-25 | - | Årsstämma |
| 2022-05-18 | - | Kvartalsrapport 2022-Q1 |
| 2022-02-23 | - | Bokslutskommuniké 2021 |
| 2021-11-18 | - | Kvartalsrapport 2021-Q3 |
| 2021-08-25 | - | Kvartalsrapport 2021-Q2 |
| 2021-05-27 | - | X-dag ordinarie utdelning RAY B 0.00 SEK |
| 2021-05-26 | - | Årsstämma |
| 2021-05-05 | - | Kvartalsrapport 2021-Q1 |
| 2021-02-23 | - | Bokslutskommuniké 2020 |
| 2020-11-18 | - | Kvartalsrapport 2020-Q3 |
| 2020-08-26 | - | Kvartalsrapport 2020-Q2 |
| 2020-07-01 | - | X-dag ordinarie utdelning RAY B 0.00 SEK |
| 2020-06-30 | - | Årsstämma |
| 2020-05-05 | - | Kvartalsrapport 2020-Q1 |
| 2020-02-14 | - | Bokslutskommuniké 2019 |
| 2019-11-14 | - | Kvartalsrapport 2019-Q3 |
| 2019-08-20 | - | Kvartalsrapport 2019-Q2 |
| 2019-05-22 | - | X-dag ordinarie utdelning RAY B 0.00 SEK |
| 2019-05-21 | - | Årsstämma |
| 2019-05-09 | - | Kvartalsrapport 2019-Q1 |
| 2019-02-20 | - | Bokslutskommuniké 2018 |
| 2018-11-15 | - | Kvartalsrapport 2018-Q3 |
| 2018-08-23 | - | Kvartalsrapport 2018-Q2 |
| 2018-05-31 | - | X-dag ordinarie utdelning RAY B 0.00 SEK |
| 2018-05-29 | - | Årsstämma |
| 2018-05-09 | - | Kvartalsrapport 2018-Q1 |
| 2018-02-15 | - | Bokslutskommuniké 2017 |
| 2017-11-22 | - | Kvartalsrapport 2017-Q3 |
| 2017-08-24 | - | Kvartalsrapport 2017-Q2 |
| 2017-05-24 | - | X-dag ordinarie utdelning RAY B 0.00 SEK |
| 2017-05-23 | - | Årsstämma |
| 2017-05-19 | - | Kvartalsrapport 2017-Q1 |
| 2017-02-17 | - | Bokslutskommuniké 2016 |
| 2016-11-18 | - | Kvartalsrapport 2016-Q3 |
| 2016-08-25 | - | Kvartalsrapport 2016-Q2 |
| 2016-05-18 | - | X-dag ordinarie utdelning RAY B 0.25 SEK |
| 2016-05-17 | - | Årsstämma |
| 2016-05-12 | - | Kvartalsrapport 2016-Q1 |
| 2016-02-18 | - | Bokslutskommuniké 2015 |
| 2015-11-25 | - | Kvartalsrapport 2015-Q3 |
| 2015-08-28 | - | Kvartalsrapport 2015-Q2 |
| 2015-05-29 | - | X-dag ordinarie utdelning RAY B 0.00 SEK |
| 2015-05-28 | - | Årsstämma |
| 2015-05-08 | - | Kvartalsrapport 2015-Q1 |
| 2015-02-12 | - | Bokslutskommuniké 2014 |
| 2014-11-27 | - | Kvartalsrapport 2014-Q3 |
| 2014-08-27 | - | Kvartalsrapport 2014-Q2 |
| 2014-05-28 | - | X-dag ordinarie utdelning RAY B 0.00 SEK |
| 2014-05-27 | - | Årsstämma |
| 2014-05-16 | - | Kvartalsrapport 2014-Q1 |
| 2014-02-13 | - | Bokslutskommuniké 2013 |
| 2013-11-27 | - | Kvartalsrapport 2013-Q3 |
| 2013-08-28 | - | Kvartalsrapport 2013-Q2 |
| 2013-05-23 | - | X-dag ordinarie utdelning RAY B 0.00 SEK |
| 2013-05-22 | - | Årsstämma |
| 2013-05-16 | - | Kvartalsrapport 2013-Q1 |
| 2013-02-14 | - | Bokslutskommuniké 2012 |
| 2012-11-16 | - | Kvartalsrapport 2012-Q3 |
| 2012-08-28 | - | Kvartalsrapport 2012-Q2 |
| 2012-05-31 | - | X-dag ordinarie utdelning RAY B 0.00 SEK |
| 2012-05-30 | - | Årsstämma |
| 2012-05-23 | - | Kvartalsrapport 2012-Q1 |
| 2012-02-16 | - | Bokslutskommuniké 2011 |
| 2011-11-24 | - | Kvartalsrapport 2011-Q3 |
| 2011-05-26 | - | X-dag ordinarie utdelning RAY B 0.50 SEK |
| 2011-05-25 | - | Årsstämma |
| 2011-05-04 | - | Kvartalsrapport 2011-Q1 |
| 2011-02-18 | - | Bokslutskommuniké 2010 |
| 2010-11-12 | - | Kvartalsrapport 2010-Q3 |
| 2010-08-27 | - | Kvartalsrapport 2010-Q2 |
| 2010-05-26 | - | X-dag ordinarie utdelning RAY B 0.50 SEK |
| 2010-05-25 | - | Årsstämma |
| 2010-05-11 | - | Kvartalsrapport 2010-Q1 |
| 2009-11-20 | - | Kvartalsrapport 2009-Q3 |
| 2009-08-27 | - | Kvartalsrapport 2009-Q2 |
| 2009-05-27 | - | X-dag ordinarie utdelning RAY B 0.00 SEK |
| 2009-05-26 | - | Årsstämma |
| 2009-05-15 | - | Kvartalsrapport 2009-Q1 |
| 2008-06-25 | - | Split RAY B 1:3 |
| 2003-06-10 | - | Split RAY B 20:1 |
Beskrivning
| Land | Sverige |
|---|---|
| Lista | Mid Cap Stockholm |
| Sektor | Hälsovård |
| Industri | Medicinteknik |
RaySearch Laboratories AB (publ) has received a new RayStation®* order to support advanced proton therapy at Stanford Health Care. The order adds tools for advanced proton arc therapy, including support for upright treatments.
Building on the initial adoption of RayStation® for treatment planning on Accuray CyberKnife® systems in the second quarter of 2024, the new licenses will enable the use of RayStation with the newly FDA-cleared Mevion FIT® system for proton therapy at Stanford Health Care.
Mevion FIT is a fully integrated system combining Mevion’s proton therapy beam delivery with Leo Cancer Care’s patient positioning and imaging systems, forming a compact solution for proton therapy. RaySearch has long-standing collaborations with both Leo Cancer Care and Mevion, and continuously adapts RayStation to support the latest innovations from both companies.
Johan Löf, founder and CEO, RaySearch, comments: “Innovation happens when hardware, software, and clinical expertise come together. Our collaboration with Stanford Health Care, Mevion, and Leo Cancer Care is a strong example of this—bringing together leading technologies and clinicians to shape the future of cancer treatment.”
For more information, please contact:
Johan Löf, founder and CEO, RaySearch Laboratories AB
Telephone: +46 (0) 8 510 530 00
Carolina Strömlid, Head of Investor Relations, RaySearch Laboratories AB
Telephone: +46 (0) 708 807 173
ir@raysearchlabs.com
About RaySearch
RaySearch Laboratories AB (publ) is a medical technology company that develops innovative software solutions for improved cancer treatment. RaySearch markets the RayStation®* treatment planning system (TPS) and the oncology information system (OIS) RayCare®*. The most recent additions to the RaySearch product line are RayIntelligence® and RayCommand®*. RayIntelligence is an oncology analytics system (OAS) which enables cancer clinics to collect, structure and analyze data. RayCommand, a treatment control system (TCS), is designed to link the treatment machine and the treatment planning and oncology information systems. RaySearch’s software has been sold to over 1,100 clinics in 47 countries. The company was founded in 2000 as a spin-off from the Karolinska Institute in Stockholm and the share has been listed on Nasdaq Stockholm since 2003 (STO: RAY B). More information is available at raysearchlabs.com.
About RayStation
RayStation®* is a flexible, innovative treatment planning system, chosen by many leading cancer centers worldwide. It combines unique features such as unmatched adaptive therapy capabilities, multi-criteria optimization, market-leading algorithms for treatment plan optimization for HDR brachytherapy and external beam therapy with photons, electrons, and protons, as well as helium and carbon ions. RayStation supports a wide range of treatment machines, providing one control center for all treatment planning needs and ensuring centers get greater value from existing equipment. RayStation also seamlessly integrates with RayCare®*. By harmonizing the treatment planning, the care of cancer patients worldwide is improved.
* Subject to regulatory clearance in some markets.